← United States · Coverage record
US · SEC FORM 4
Milestone Pharmaceuticals Inc.
MIST · Nasdaq · CIK 0001408443 · Healthcare · Biotechnology
INSIDER SIGNAL
0 qualifying P purchase groups
in the current 180-day scoring window
0 Form 4 transaction lines observed in the same window
0 sales · 0 option, withholding, award, gift or other lines
WHY NO ACTIVE SIGNAL?
Score anatomy
No score is calculated because there is no qualifying purchase in the active window. Unavailable inputs are not treated as zero or as a bearish signal.
Why is there no score?
- No qualifying open-market purchase supplies cluster, size, role, recency or conviction inputs.
- Sales and other Form 4 activity remain visible as context and do not create a negative score.
Sales and other Form 4 activity are shown separately and do not create a negative buy signal. Absence of buying is not scored as bearish.
Insider activity timeline
No Form 4 transaction event is present in the current 180-day window.
Purchase breadth, concentration & cluster buying
These modules activate when qualifying purchases enter the 180-day research window.
SIGNAL HISTORY
Scores are archived only when the company qualifies for a published US buy-signal snapshot. Last qualifying purchase: 2022-12-05 · Bharucha David.
Recent Form 4 activity
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
Market context
Market context has not been captured for this ticker yet. The daily market-context job processes the US universe in rotating batches.
Short interest
Short interest is external context reported to FINRA by broker-dealers. It does not affect the Insider Signal.
- Shares short
- 19,009,468
- Previous report
- 18,361,683
- Avg daily volume
- 1,189,684
- Days to cover
- 16.0
FINRA settlement date: 2026-09-30 · Captured 2026-10-12 · FINRA equity short interest ↗. A share count, published about a week after each of two settlement dates a month; not a percentage of shares outstanding.
Historical equity purchases
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2022-12-05 | Bharucha David | Purchase (P) | Common Shares | 7,000 | USD 4.69 | USD 32,830 | SEC filing ↗ |
| 2022-12-01 | Bharucha David | Purchase (P) | Common Shares | 3,000 | USD 4.86 | USD 14,580 | SEC filing ↗ |
| 2022-10-21 | Liebert Debra K. | Purchase (P) | Common Shares | 4,000 | USD 5.26 | USD 21,040 | SEC filing ↗ |
| 2022-10-20 | Pasternak Richard C | Purchase (P) | Common Shares | 10,000 | USD 5.20 | USD 52,000 | SEC filing ↗ |
| 2022-10-20 | Liebert Debra K. | Purchase (P) | Common Shares | 10,000 | USD 5.29 | USD 52,900 | SEC filing ↗ |
| 2022-10-19 | Wills Robert James | Purchase (P) | Common Shares | 15,000 | USD 4.93 | USD 73,950 | SEC filing ↗ |
| 2022-10-19 | TOMSICEK MICHAEL JOHN | Purchase (P) | Common Shares | 15,000 | USD 5.32 | USD 79,800 | SEC filing ↗ |
| 2022-09-07 | RTW INVESTMENTS, LP; WONG RODERICK | Purchase (P) | Common Shares, no par value ("Common Shares") | 1,557,346 | USD 8.71 | USD 13,564,484 | SEC filing ↗ |
| 2022-05-31 | TRUEX PAUL F | Purchase (P) | Common Shares | 5,000 | USD 5.60 | USD 28,000 | SEC filing ↗ |
| 2020-03-19 | RTW INVESTMENTS, LP; WONG RODERICK | Purchase (P) | Common Shares | 5,870 | USD 10.87 | USD 63,807 | SEC filing ↗ |
| 2020-03-18 | RTW INVESTMENTS, LP; WONG RODERICK | Purchase (P) | Common Shares | 2,705 | USD 10.36 | USD 28,024 | SEC filing ↗ |
| 2020-03-02 | RTW INVESTMENTS, LP; WONG RODERICK | Purchase (P) | Common Shares | 78,263 | USD 18.95 | USD 1,483,084 | SEC filing ↗ |
| 2020-01-13 | RTW INVESTMENTS, LP; WONG RODERICK | Purchase (P) | Common Shares | 270,000 | USD 16.25 | USD 4,387,500 | SEC filing ↗ |
Form 4 evidence
24 transaction lines in the latest 365-day window; 56 in local history.
| Date | Owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2026-04-16 | Oliveto Joseph | Sale (S) | Common Shares | 36,500 | USD 2.26 | USD 82,490 | SEC filing ↗ |
| 2026-01-26 | Oliveto Joseph | Sale (S) | Common Shares | 34,523 | USD 1.93 | USD 66,629 | SEC filing ↗ |
| 2026-01-26 | Oliveto Joseph | Option exercise / conversion (M) | Common Shares | 66,600 | USD — | USD — | SEC filing ↗ |
Show recent Form 4 evidence (24 grouped rows)
| Date | Owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2026-04-16 | Oliveto Joseph | Sale (S) | Common Shares | 36,500 | USD 2.26 | USD 82,490 | SEC filing ↗ |
| 2026-01-26 | Oliveto Joseph | Sale (S) | Common Shares | 34,523 | USD 1.93 | USD 66,629 | SEC filing ↗ |
| 2026-01-26 | Oliveto Joseph | Option exercise / conversion (M) | Common Shares | 66,600 | USD — | USD — | SEC filing ↗ |
| 2026-01-26 | Nelson Jeffrey Edward | Sale (S) | Common Shares | 12,245 | USD 1.93 | USD 23,633 | SEC filing ↗ |
| 2026-01-26 | Nelson Jeffrey Edward | Option exercise / conversion (M) | Common Shares | 20,100 | USD — | USD — | SEC filing ↗ |
| 2026-01-26 | Muller Lorenz | Sale (S) | Common Shares | 11,180 | USD 1.93 | USD 21,577 | SEC filing ↗ |
| 2026-01-26 | Muller Lorenz | Option exercise / conversion (M) | Common Shares | 20,100 | USD — | USD — | SEC filing ↗ |
| 2026-01-26 | Hasija Amit | Sale (S) | Common Shares | 12,245 | USD 1.93 | USD 23,633 | SEC filing ↗ |
| 2026-01-26 | Hasija Amit | Option exercise / conversion (M) | Common Shares | 20,100 | USD — | USD — | SEC filing ↗ |
| 2026-01-26 | Bharucha David | Sale (S) | Common Shares | 12,245 | USD 1.93 | USD 23,633 | SEC filing ↗ |
| 2026-01-26 | Bharucha David | Option exercise / conversion (M) | Common Shares | 20,100 | USD — | USD — | SEC filing ↗ |
| 2026-01-08 | Oliveto Joseph | Sale (S) | Common Shares | 43,000 | USD 2.25 | USD 96,750 | SEC filing ↗ |
| 2026-01-07 | Oliveto Joseph | Sale (S) | Common Shares | 500 | USD 2.25 | USD 1,125 | SEC filing ↗ |
| 2025-12-15 | Oliveto Joseph | Sale (S) | Common Shares | 133,054 | USD 2.32 | USD 308,685 | SEC filing ↗ |
| 2025-12-15 | Nelson Jeffrey Edward | Sale (S) | Common Shares | 58,007 | USD 2.32 | USD 134,576 | SEC filing ↗ |
| 2025-12-15 | Muller Lorenz | Sale (S) | Common Shares | 53,566 | USD 2.32 | USD 124,273 | SEC filing ↗ |
| 2025-12-15 | Hasija Amit | Sale (S) | Common Shares | 58,007 | USD 2.32 | USD 134,576 | SEC filing ↗ |
| 2025-12-15 | Bharucha David | Sale (S) | Common Shares | 58,007 | USD 2.32 | USD 134,576 | SEC filing ↗ |
| 2025-12-12 | Oliveto Joseph | Award / grant (A) | Common Shares | 280,000 | USD — | USD — | SEC filing ↗ |
| 2025-12-12 | Nelson Jeffrey Edward | Award / grant (A) | Common Shares | 100,000 | USD — | USD — | SEC filing ↗ |
| 2025-12-12 | Muller Lorenz | Award / grant (A) | Common Shares | 100,000 | USD — | USD — | SEC filing ↗ |
| 2025-12-12 | Hasija Amit | Award / grant (A) | Common Shares | 100,000 | USD — | USD — | SEC filing ↗ |
| 2025-12-12 | Bharucha David | Award / grant (A) | Common Shares | 100,000 | USD — | USD — | SEC filing ↗ |
| 2025-12-09 | Muller Lorenz | Gift (G) | Common Shares | 25,000 | USD 0.00 | USD 0 | SEC filing ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
Snapshot & identity
| Snapshot date | 2026-10-18 |
|---|---|
| Ranking version | US-v1.2 |
| Data quality | PASS ELIGIBLE · — |
| Ticker | MIST |
| CIK | 0001408443 |
| Sector | Healthcare |
| Industry | Biotechnology Yahoo Finance |
| SEC SIC | 2834 Pharmaceutical Preparations |
| Exchange | Nasdaq |
Data coverage
| Local Form 4 history | 56 transaction lines from 2020-01-13 to 2026-04-16 13 P purchase lines · 16 S sale lines · 27 other lines |
|---|---|
| SEC company submissions | Open SEC filings ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.